Persistence of antibiotic resistant bacteria

被引:317
作者
Andersson, DI [1 ]
机构
[1] Swedish Inst Infect Dis Control, Dept Bacteriol, S-17182 Stockholm, Sweden
关键词
D O I
10.1016/j.mib.2003.09.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacterial adaptation to antibiotics has been very successful and over the past decade the increase in antibiotic resistance has generated considerable medical problems. Even though many drug resistances confer a fitness cost, suggesting that they might disappear by reducing the volume of antibiotic use, increasing evidence obtained from laboratory and epidemiological studies indicate that several processes will act to cause long-term persistence of resistant bacteria. Compensatory evolution that ameliorates the costs of resistance, the occurrence of cost-free resistances and genetic linkage between non-selected and selected resistances will confer a stabilization of the resistant bacteria. Thus, it is of importance that we forcefully implement strategies to reduce the rate of appearance and spread of resistant bacteria to allow new drug discovery to catch up with bacterial resistance development.
引用
收藏
页码:452 / 456
页数:5
相关论文
共 39 条
[1]   The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].
Austin, DJ ;
Kristinsson, KG ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156
[2]   Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis [J].
Billington, OJ ;
McHugh, TD ;
Gillespie, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1866-1869
[3]   Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori [J].
Björkholm, B ;
Sjölund, M ;
Falk, PG ;
Berg, OG ;
Engstrand, L ;
Andersson, DI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14607-14612
[4]   Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance [J].
Björkman, J ;
Nagaev, I ;
Berg, OG ;
Hughes, D ;
Andersson, DI .
SCIENCE, 2000, 287 (5457) :1479-1482
[5]   The frequency of mutators in populations of Escherichia coli [J].
Boe, L ;
Danielsen, M ;
Knudsen, S ;
Petersen, JB ;
Maymann, J ;
Jensen, PR .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 448 (01) :47-55
[6]   The effect of drug resistance on the fitness of Mycobacterium tuberculosis [J].
Cohen, T ;
Sommers, B ;
Murray, M .
LANCET INFECTIOUS DISEASES, 2003, 3 (01) :13-21
[7]   Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment [J].
Davies, AP ;
Billington, OJ ;
Bannister, BA ;
Weir, WRC ;
McHugh, TD ;
Gillespie, SH .
JOURNAL OF INFECTION, 2000, 41 (02) :184-187
[8]   The fate of microbial mutators [J].
de Visser, JAGM .
MICROBIOLOGY-SGM, 2002, 148 :1247-1252
[9]   High frequency of mutator strains among human uropathogenic Escherichia coli isolates [J].
Denamur, E ;
Bonacorsi, S ;
Giraud, A ;
Duriez, P ;
Hilali, F ;
Amorin, C ;
Bingen, E ;
Andremont, A ;
Picard, B ;
Taddei, F ;
Matic, I .
JOURNAL OF BACTERIOLOGY, 2002, 184 (02) :605-609
[10]   Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction [J].
Enne, VI ;
Livermore, DM ;
Stephens, P ;
Hall, LMC .
LANCET, 2001, 357 (9265) :1325-1328